Phage Display Reveals VLRB-Mediated Recognition of Minimal Tumor Glycan Antigen Sialyl-Tn
Current Issues in Molecular Biology · 26.09.2025 · 47 (10) · 802
DOI: 10.3390/cimb47100802 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Issues in Molecular Biology, online erschienen am 26.09.2025. Verfasst von Mark Rickard N Angelia und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Aquatic Animal Diseases, Institute of Animal Medicine, College of Veterinary Medicine, Gyeongsang National University, 501, Jinju-Daero…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The National Research Foundation of Korea, National Research Foundation of Korea.
Abstract (Originalsprache)
Sialyl-Tn (sTn) is a tumor-associated carbohydrate antigen (TACA) abundantly expressed by various types of carcinomas. While conventional antibody-based platforms have traditionally been used for the detection and targeting of sTn, alternative binding scaffolds may offer distinct advantages. Variable lymphocyte receptor B (VLRB), the immunoglobulin-like molecule of jawless vertebrates, offers a promising alternative for glycan recognition. In this study, a phage-displayed VLRB library was utilized to identify sTn-specific binders. Two candidates, designated as ccombodies A8 and B11, were isolated after four rounds of biopanning. Both were expressed and purified using Ni-affinity and FPLC, yielding proteins with apparent molecular weights of ~27 kDa in SDS-PAGE. Sequence analysis revealed a preference for glycan-binding residues in randomized hypervariable regions, with A8 exhibiting an increased aliphatic content. ELISA confirmed selective binding to sTn and other O-glycans containing the core α-GalNAc, with EC50 values of 18.2 and 14.2 nM for A8 and B11, respectively. Vicia villosa lectin inhibited ccombody binding to sTn, indicating shared epitope recognition. Additionally, both ccombodies bound to sTn-positive glycoproteins and carcinoma cell lines HeLa and LS174T. These findings demonstrate that phage display of VLRBs enables the identification of high-affinity, glycan-specific binders, offering a compelling alternative to immunoglobulin-based platforms for future diagnostic and therapeutic applications targeting tumor-associated glycans.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Aquatic Animal Diseases, Institute of Animal Medicine, College of Veterinary Medicine, Gyeongsang National University, 501, Jinju-Daero, Jinju-si 52828, Republic of Korea.
- Institute of Chemistry, College of Arts and Sciences, University of the Philippines Los Baños, College, Laguna 4031, Philippines.
- Moredun Research Institute, Pentlands Science Park, Bush Loan, Midlothian EH26 0PZ, UK.
- Earwynbio Co., Ltd., 206 Sungjangjiwon-dong, 991 Worasan-ro, Munsan, Jinju-si 52839, Republic of Korea.
ORCID-Profile: Cheolung Yang, Kim D Thompson, Taesung Jung
Förderung
- The National Research Foundation of Korea
- National Research Foundation of Korea
Zitieren
APA
Angelia, M. R. N., Rodelas-Angelia, A. J. D., Kim, Y., Yang, C., Jang, H., Jeong, S., Mun, J., Thompson, K. D., & Jung, T. (2025). Phage Display Reveals VLRB-Mediated Recognition of Minimal Tumor Glycan Antigen Sialyl-Tn. Current Issues in Molecular Biology, 47(10), 802. https://doi.org/10.3390/cimb47100802
Vancouver
Angelia MRN, Rodelas-Angelia AJD, Kim Y, Yang C, Jang H, Jeong S, et al. Phage Display Reveals VLRB-Mediated Recognition of Minimal Tumor Glycan Antigen Sialyl-Tn. Current Issues in Molecular Biology. 2025;47(10):802. doi:10.3390/cimb47100802
BibTeX
@article{Angelia2025,
author = {Angelia, Mark Rickard N and Rodelas-Angelia, Abigail Joy D and Kim, Youngrim and Yang, Cheolung and Jang, Hyeok and Jeong, Seungpyo and Mun, Jihyun and Thompson, Kim D and Jung, Taesung},
title = {Phage Display Reveals VLRB-Mediated Recognition of Minimal Tumor Glycan Antigen Sialyl-Tn},
journal = {Current Issues in Molecular Biology},
year = {2025},
volume = {47},
number = {10},
pages = {802},
doi = {10.3390/cimb47100802}
}
EUVIMED